Literature DB >> 3951698

Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: clinicoanatomic correlations.

A Hijdra, J Van Gijn, S Stefanko, K J Van Dongen, M Vermeulen, H Van Crevel.   

Abstract

Fifty-seven of 176 prospectively studied patients with aneurysmal subarachnoid hemorrhage (SAH) developed delayed cerebral ischemia. Clinical features included hemispheric focal signs (13), decrease in level of consciousness (14), or both (30), and mutism (15). Forty-seven patients showed hypodense lesions on CT in one (19) or multiple vascular territories (22), or diffusely in one or both hemispheres (6). Twenty-eight had symmetric decrease in ventricular size. Of 18 autopsied patients, only 1 had a purely univascular lesion. The clinical, CT, and pathologic features suggest that delayed cerebral ischemia after SAH is a multivascular or diffuse process in most patients.

Entities:  

Mesh:

Year:  1986        PMID: 3951698     DOI: 10.1212/wnl.36.3.329

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  43 in total

1.  Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design.

Authors:  Jose I Suarez; Renee H Martin
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

2.  Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.

Authors:  Jared M Pisapia; Xiangsheng Xu; Jane Kelly; Jamie Yeung; Geneive Carrion; Huaiyu Tong; Sudha Meghan; Omar M El-Falaky; M Sean Grady; Douglas H Smith; Sergei Zaitsev; Vladimir R Muzykantov; Michael F Stiefel; Sherman C Stein
Journal:  Exp Neurol       Date:  2011-11-04       Impact factor: 5.330

3.  Reversibility of extensive hemispheric cytotoxic cerebral edema following subarachnoid hemorrhage.

Authors:  Nancy McLaughlin; Michel W Bojanowski
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 4.  Current diagnostic approaches to subarachnoid haemorrhage.

Authors:  Jean Marie U-King-Im; Brendan Koo; Rikin A Trivedi; Nicholas J Higgins; Keng Y Tay; Justin J Cross; Nagui M Antoun; Jonathan H Gillard
Journal:  Eur Radiol       Date:  2005-02-12       Impact factor: 5.315

Review 5.  An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage.

Authors:  Jasper H van Lieshout; Maxine Dibué-Adjei; Jan F Cornelius; Philipp J Slotty; Toni Schneider; Tanja Restin; Hieronymus D Boogaarts; Hans-Jakob Steiger; Athanasios K Petridis; Marcel A Kamp
Journal:  Neurosurg Rev       Date:  2017-02-18       Impact factor: 3.042

6.  Bleeding in the brain: Killer waves of depolarization in subarachnoid bleed.

Authors:  Costantino Iadecola
Journal:  Nat Med       Date:  2009-10       Impact factor: 53.440

7.  Outcome of patients with aneurysmal and presumed aneurysmal bleeding. A hospital study based on 100 consecutive cases in a neurological clinic.

Authors:  H Schütz; P Krack; B Buchinger; R H Bödeker; A Laun; W Dorndorf; A Agnoli
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

8.  MRI Detection of Cerebral Infarction in Subarachnoid Hemorrhage.

Authors:  Georgia Korbakis; Shyam Prabhakaran; Sayona John; Rajeev Garg; James J Conners; Thomas P Bleck; Vivien H Lee
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

9.  Intensive therapies of delayed cerebral ischemia after subarachnoid hemorrhage: a propensity-matched comparison of different center-driven strategies.

Authors:  Marc-Antoine Labeyrie; Davide Simonato; Sergios Gargalas; Louis Morisson; Jonathan Cortese; Mario Ganau; Maurizio Fuschi; Jash Patel; Sébastien Froelich; Samuel Gaugain; Benjamin Chousterman; Emmanuel Houdart
Journal:  Acta Neurochir (Wien)       Date:  2021-07-24       Impact factor: 2.216

10.  Single photon emission computed tomography in patients with acute hydrocephalus or with cerebral ischaemia after subarachnoid haemorrhage.

Authors:  D Hasan; J van Peski; I Loeve; E P Krenning; M Vermeulen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.